Form4insider filings, from the source

SEC Form 3 · accession 0001493152-17-004197

VBI VACCINES INC. · VBIV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeff Baxter
Officer — President and CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Apr 19, 2017 · 8:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000704159

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, no par value per shareholding———69,005D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (RSUs)F1,F2$0.00holding————Jun 14, 2026Common Shares93,750—D
Option (Right to Buy Common Shares)F3$5.06holding————Nov 13, 2019Common Shares116,420—D
Option (Right to Buy Common Shares)F3$2.50holding————Mar 29, 2022Common Shares19,771—D
Option (Right to Buy Common Shares)F3$2.50holding————Apr 2, 2022Common Shares15,306—D
Option (Right to Buy Common Shares)F4$4.13holding————Jul 25, 2024Common Shares392,089—D
Option (Right to Buy Common Shares)F5$4.93holding————Jul 30, 2025Common Shares156,062—D

Explanation of responses